The plasminogen activator/plasmin system

Journal of Clinical Investigation

Volumn 88, Issue 4, 1991, Pages 1067-1072

  Vassalli, Jean Dominique ^a   Sappino, André Pascal ^a   Belin, Dominique ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; PLASMINOGEN ACTIVATOR;

HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ANIMAL; BINDING SITES; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; PLASMIN; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; SUPPORT, NON-U.S. GOV'T;

EID: 0026053146     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115405     Document Type: Article

References (20)

1. Dano, K., P. A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-266.
2. Petersen, L. C., L. R. Lund, L. S. Nielsen, K. Dano, and L. Skriver. 1988. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J. Biol. Chem. 263:11189-11195.
3. Kobayashi, H., M. Schmitt, L. Goretzki, N. Chucholowski, J. Calvete, M. Kramer, W. A. Günzler, F. Jänicke, and H. Graeff. 1991. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA). J. Biol. Chem. 266:5147-5152.
4. r 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100:86-92.
5. Blasi, F., N. Behrendt, M. V. Cubellis, V. Ellis, L. R. Lund, M. T. Masucci, L. B. Moller, D. P. Olson, N. Pedersen, M. Ploug, E. Ronne, and K. Dano. 1990. The urokinase receptor and regulation of cell surface plasminogen activation. Cell Differ. Dev. 32:247-254.
6. Gething, M. J., B. Adler, J. A. Boose, R. D. Gerard, E. L. Madison, D. McGookey, R. S. Meidell, L. M. Roman, and J. Sambrook. 1988. Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO (Eur. Mol. Biol. Organ.) J. 7:2731-2740.
7. Andrade-Gordon, P., and S. Strickland. 1986. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. Biochemistry. 25:4033-4040.
8. Quigley, J. P., M. B. Berkenpas, R. T. Aimes, and J. M. Chen. 1990. Serine protease and metalloprotease cascade systems involved in pericellular proteolysis. Cell Differ. Dev. 32:263-276.
9. Plow, E. F., and L. A. Miles. 1990. Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differ. Dev. 32:293-298.
10. He, C. S., S. M. Wilhelm, A. P. Pentland, B. L. Marmer, G. A. Grant, A. Z. Eisen, and G. I. Goldberg. 1989. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA. 86:2632-2636.
11. Nusrat, A. R., and H. A. Chapman. 1991. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87:1091-1097.
12. Sappino, A.-P., J. Huarte, D. Belin, and J.-D. Vassalli. 1989. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell Biol. 109:2471-2479.
13. Valinsky, J. E., E. Reich, and N. Le Douarin. 1981. Plasminogen activator in the bursa of Fabricius: correlations with morphogenetic remodeling and cell migrations. Cell. 25:471-476.
14. Festoff, B. W., editor. 1990. Serine proteases and their serpin inhibitors in the nervous system. In Regulation in Development and in Degenerative and Malignant disease. Plenum Publishing Corp., New York.
15. Tsafriri, A., T. A. Bicsak, S. B. Cajander, T. Ny, and A. J. Hsueh. 1989. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. Endocrinology. 124:415-421.
16. Huarte, J., D. Belin, and J.-D. Vassalli. 1985. Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation. Cell. 43:551-558.
17. Pepper, M. S., and R. Montesano. 1990. Proteolytic balance and capillary morphogenesis. Cell Differ. Dev. 32:319-328.
18. Sappino, A.-P., D. Belin, J. Huarte, S. Hirschel-Scholz, J. H. Saurat, and J.-D. Vassalli. 1991. Differential protease expression by cutaneous squamous and basal cell carcinomas. J. Clin. Invest. 88:1074-1080.
19. Sappino, A.-P., J. Huarte, J.-D. Vassalli, and D. Belin. 1991. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J. Clin. Invest. 87:962-970.
20. Gross, J. L., M. N. Krupp, D. B. Rifkin, and M. D. Lane. 1983. Downregulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells. Proc. Nail. Acad. Sci. USA. 80:2276-2280.